blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2297319

EP2297319 - GROWTH FACTORS FOR PRODUCTION OF DEFINITIVE ENDODERM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.08.2016
Database last updated on 29.07.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG
published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
VIACYTE, INC.
3550 General Atomics Court Building No 2-503
San Diego, CA 92121 / US
[2011/14]
Former [2011/12]For all designated states
Cythera Inc.
3550 General Atomics Court Bldg. 2, Room 503
San Diego, CA 92121 / US
Inventor(s)01 / D'AMOUR, Kevin, Allen
2739 East Evans Road
San Diego CA 92106 / US
 [2011/12]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2015/41]
Former [2011/12]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date08756668.303.06.2008
[2011/12]
WO2008US65686
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009154606
Date:23.12.2009
Language:EN
[2009/52]
Type: A1 Application with search report 
No.:EP2297319
Date:23.03.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 23.12.2009 takes the place of the publication of the European patent application.
[2011/12]
Type: B1 Patent specification 
No.:EP2297319
Date:07.10.2015
Language:EN
[2015/41]
Search report(s)International search report - published on:KR23.12.2009
(Supplementary) European search report - dispatched on:EP04.08.2011
ClassificationIPC:C12N5/0735, C12N15/09, C12P21/02
[2015/19]
CPC:
C12N5/0676 (EP); C12N5/0606 (EP); C12N2501/115 (EP);
C12N2501/117 (EP); C12N2501/16 (EP); C12N2501/19 (EP);
C12N2501/415 (EP); C12N2501/70 (EP); C12N2506/02 (EP) (-)
Former IPC [2011/12]C12N15/09, C12N5/00, C12P21/02
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/41]
Former [2011/12]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:WACHSTUMSFAKTOREN ZUR HERSTELLUNG VON DEFINITIVEM ENDODERM[2011/12]
English:GROWTH FACTORS FOR PRODUCTION OF DEFINITIVE ENDODERM[2011/12]
French:FACTEURS DE CROISSANCE POUR LA PRODUCTION DE L'ENDODERME DÉFINITIF[2011/12]
Entry into regional phase23.12.2010National basic fee paid 
23.12.2010Search fee paid 
23.12.2010Designation fee(s) paid 
23.12.2010Examination fee paid 
Examination procedure23.12.2010Examination requested  [2011/12]
10.04.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
06.06.2012Amendment by applicant (claims and/or description)
28.09.2012Despatch of a communication from the examining division (Time limit: M06)
08.04.2013Reply to a communication from the examining division
18.04.2013Despatch of a communication from the examining division (Time limit: M04)
16.05.2013Reply to a communication from the examining division
15.05.2014Despatch of a communication from the examining division (Time limit: M04)
24.09.2014Reply to a communication from the examining division
22.04.2015Communication of intention to grant the patent
24.08.2015Fee for grant paid
24.08.2015Fee for publishing/printing paid
24.08.2015Receipt of the translation of the claim(s)
Divisional application(s)EP15183719.2  / EP2993226
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.09.2012
Opposition(s)08.07.2016No opposition filed within time limit [2016/37]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
06.06.2012Request for further processing filed
06.06.2012Full payment received (date of receipt of payment)
Request granted
25.06.2012Decision despatched
Fees paidRenewal fee
23.12.2010Renewal fee patent year 03
27.06.2011Renewal fee patent year 04
31.03.2012Renewal fee patent year 05
27.06.2013Renewal fee patent year 06
31.03.2014Renewal fee patent year 07
29.06.2015Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.06.2008
AT07.10.2015
BG07.10.2015
CY07.10.2015
CZ07.10.2015
EE07.10.2015
ES07.10.2015
FI07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
PL07.10.2015
RO07.10.2015
SI07.10.2015
SK07.10.2015
TR07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
IE03.06.2016
LU03.06.2016
MT30.06.2016
[2018/38]
Former [2018/32]HU03.06.2008
AT07.10.2015
CY07.10.2015
CZ07.10.2015
EE07.10.2015
ES07.10.2015
FI07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
PL07.10.2015
RO07.10.2015
SI07.10.2015
SK07.10.2015
TR07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
IE03.06.2016
LU03.06.2016
MT30.06.2016
Former [2018/29]HU03.06.2008
AT07.10.2015
CY07.10.2015
CZ07.10.2015
EE07.10.2015
ES07.10.2015
FI07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
PL07.10.2015
RO07.10.2015
SI07.10.2015
SK07.10.2015
TR07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
IE03.06.2016
LU03.06.2016
Former [2018/28]HU03.06.2008
AT07.10.2015
CY07.10.2015
CZ07.10.2015
EE07.10.2015
ES07.10.2015
FI07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
PL07.10.2015
RO07.10.2015
SI07.10.2015
SK07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
IE03.06.2016
Former [2017/38]AT07.10.2015
CZ07.10.2015
EE07.10.2015
ES07.10.2015
FI07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
PL07.10.2015
RO07.10.2015
SI07.10.2015
SK07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
IE03.06.2016
Former [2017/07]AT07.10.2015
CZ07.10.2015
EE07.10.2015
ES07.10.2015
FI07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
LV07.10.2015
MC07.10.2015
PL07.10.2015
RO07.10.2015
SI07.10.2015
SK07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/49]AT07.10.2015
CZ07.10.2015
EE07.10.2015
ES07.10.2015
FI07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
LV07.10.2015
PL07.10.2015
RO07.10.2015
SI07.10.2015
SK07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/36]AT07.10.2015
CZ07.10.2015
EE07.10.2015
ES07.10.2015
FI07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
LV07.10.2015
PL07.10.2015
RO07.10.2015
SK07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/34]AT07.10.2015
CZ07.10.2015
ES07.10.2015
FI07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
LV07.10.2015
PL07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/25]AT07.10.2015
ES07.10.2015
FI07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
LV07.10.2015
PL07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/24]AT07.10.2015
ES07.10.2015
FI07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
PL07.10.2015
NO07.01.2016
GR08.01.2016
IS07.02.2016
PT08.02.2016
Former [2016/23]ES07.10.2015
HR07.10.2015
IT07.10.2015
LT07.10.2015
NO07.01.2016
IS07.02.2016
Former [2016/22]ES07.10.2015
IT07.10.2015
LT07.10.2015
NO07.01.2016
IS07.02.2016
Former [2016/21]ES07.10.2015
IT07.10.2015
LT07.10.2015
NO07.01.2016
Former [2016/20]ES07.10.2015
LT07.10.2015
Documents cited:Search[A]WO2004073633  (UNIV LELAND STANFORD JUNIOR [US], et al) [A] 1-15 * page 6, line 25 - page 7, line 8 * * claims 1-2,23-27 *;
 [A]WO2007047509  (UNIV MINNESOTA [US], et al) [A] 1-15 * figures 3a, 3b, 3c *;
 [A]WO2005045001  (UNIV LELAND STANFORD JUNIOR [US], et al) [A] 1-15 * figure 1 *
 [A]  - D'AMOUR KEVIN A ET AL, "Efficient differentiation of human embryonic stem cells to definitive endoderm", NATURE BIOTECHNOLOGY, (200512), vol. 23, no. 12, ISSN 1087-0156, pages 1534 - 1541, XP002651213 [A] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1038/nbt1163
 [A]  - MCLEAN A B ET AL, "Activin A efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed", STEM CELLS 200701 US LNKD- DOI:10.1634/STEMCELLS.2006-0219, (200701), vol. 25, no. 1, ISSN 1066-5099, pages 29 - 38, XP002651214 [A] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1634/stemcells.2006-0219
International search[X]WO2005045001  (UNIV LELAND STANFORD JUNIOR [US], et al);
 [A]US6426332  (RUEGER DAVID C [US], et al)
 [A]  - HUA CHANG ET AL., "Genetic Analysis of the Mammalian Transforming Growth Factor-ß Superfamily.", ENDOCRINE REVIEWS, (200212), vol. 23, no. 6, pages 787 - 823, XP008140665

DOI:   http://dx.doi.org/10.1210/er.2002-0003
Examination   - CHUNG YOUNG ET AL, "Human embryonic stem cell lines generated without embryo destruction", CELL STEM CELL, CELL PRESS, US, (20080207), vol. 2, no. 2, doi:10.1016/J.STEM.2007.12.013, ISSN 1934-5909, pages 113 - 117, XP002604696

DOI:   http://dx.doi.org/10.1016/J.STEM.2007.12.013
by applicantUS2007154984
    - D'AMOUR ET AL., NAT BIOTECHNOL, (2006), vol. 24, no. 11, pages 1392 - 401
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.